Biotechnology

Pharmaceuticals Clinical Trials Drug Development Clinical Research Pharmaceutical Industry Pharmaceutical Companies Startups Research and Development Clinical Development Biopharmaceuticals

Multiple Law Firms File Competing Securities Suits Against ADMA Biologics

Who wins lead‑plaintiff status will determine who directs the litigation and negotiates any settlement.

Vertex to Acquire Crinetics for About $10 Billion

Novartis to Acquire Myricx Bio for Up to $1.5 Billion

Takeda Signs $600 Million‑Value AI Drug Discovery Deal With Insilico

OrbiMed Sells 860,123 Enliven Shares in Roughly $39 Million Transaction

Insilico and SK Biopharmaceuticals Sign $2.5 Billion AI Drug Discovery Deal for Neuroimmune Therapies

Biogen to Buy RayThera for Up to $1 Billion

Moderna Restructures Leadership as It Prepares for Multiple Vaccine Launches

Neumora Halts Navacaprant After Phase 3 KOASTAL Failures

Amazon Deploys AI Seller Assistant to 1.7 Million Merchants in India

Immuneel Raises ₹100 Crore Series B to Scale CAR‑T Manufacturing

Tango’s PRMT5 Inhibitor Plus Daraxonrasib Shows 92% Response in Biomarker‑Selected Pancreatic Cancer

Man Charged With Murder After Miami Beach Resident Fell From 25th-Floor Balcony

Lilly Wins Exclusive License to Ascidian RNA Exon-Editing Platform for Kidney Diseases

NewLimit Raises $435 Million to Advance First Human Trial for Liver Rejuvenation

Praxis Drug Vormatrigine Misses Primary Goal in Phase 2/3 POWER1 Trial

Servier to Buy Edgewise Muscular Dystrophy Unit for Up to $2.65 Billion

Argentina To Produce Influenza Vaccines for Latin America Through OPS Deal

Insilico Medicine and Human Life Foundation Models Partner to Build AI Foundation Models for Longevity

Colombia Signs Deal With SK Bioscience to Build Domestic Vaccine Production